CatiPep® from Taiwan: An AI-Engineered Peptide with Clinical Translation and Commercialization Potential for Precision Osteoarthritis Therapy with Global Competitiveness
Technology Introduction:
This Taiwan-first, AI-driven peptide drug development platform, centered on CatiPep®, integrates multi-omics analysis with mechanism-guided design. Supported by intellectual property protection and validated in large-animal goat preclinical studies, it promotes cartilage regeneration and suppresses inflammation. The platform is designed for disease-modifying osteoarthritis (DMOAD) and holds strong potential for clinical translation and commercialization.
Industrial Applications:
This technology establishes an AI-driven peptide drug development platform centered on CatiPep®, addressing key industry challenges in osteoarthritis (OA), including the lack of disease-modifying therapies and low development efficiency. It is applicable to new drug development, clinical medicine, and veterinary markets, enhancing development efficiency, therapeutic efficacy, and scalability, while reducing costs and translational risks, demonstrating strong clinical and commercial potential.
Far Eastern Memorial Hospital
Far Eastern Memorial Hospital is a leading academic medical center committed to excellence in patient care, clinical research, medical education, and healthcare innovation.
There was a large population during the 70's and 80's in Banqiao and Tuchen District, New Taipei City; however, there was not any modern hospital in these areas. Therefore, the seriously injured workers and ‘in critical condition’ patients had to transfer to Taipei City. Under this circumstance, many of them were delayed in receiving a proper medical treatment due to the long traveling distance. Mr. Yu-Ziang Hsu, founder of the Far Eastern Group, was aware of the situation and had based on his belief of "By the society, for the society" having Far Eastern Memorial Foundation setup for the construction of hospital, emergency rescue, free clinic for the poor and sick, and inspiring medical and medicine research. Far Eastern Memorial Hospital (FEMH) was established in Banqiao on April 1, 1981 and with 150 beds ready for service. FEHM was accredited by the Ministry of Education as the secondary teaching hospital to be in 1983, the secondary teaching hospital in 1985, district hospital in 1988, district hospital & teaching hospital in 1991 to 1997, and district hospital and Class II Teaching Hospital in 2000 to 2003.
There was a large population during the 70's and 80's in Banqiao and Tuchen District, New Taipei City; however, there was not any modern hospital in these areas. Therefore, the seriously injured workers and ‘in critical condition’ patients had to transfer to Taipei City. Under this circumstance, many of them were delayed in receiving a proper medical treatment due to the long traveling distance. Mr. Yu-Ziang Hsu, founder of the Far Eastern Group, was aware of the situation and had based on his belief of "By the society, for the society" having Far Eastern Memorial Foundation setup for the construction of hospital, emergency rescue, free clinic for the poor and sick, and inspiring medical and medicine research. Far Eastern Memorial Hospital (FEMH) was established in Banqiao on April 1, 1981 and with 150 beds ready for service. FEHM was accredited by the Ministry of Education as the secondary teaching hospital to be in 1983, the secondary teaching hospital in 1985, district hospital in 1988, district hospital & teaching hospital in 1991 to 1997, and district hospital and Class II Teaching Hospital in 2000 to 2003.
Contact Information
Name：Hsiu-Jung Liao
Tel：02-8966-7000 #4566
Address：No. 21, Sec. 2, Nanya S. Rd., Banqiao Dist., New Taipei City 220216 , Taiwan (R.O.C.)
